Enzyme linked to heart disease could help treat asthma
Washington: An enzyme, which is known for its role in heart disease, could be a promising target to treat asthma, a new study suggests.
Researchers from the University of Iowa have found that the enzyme, called CaMKII, is linked to the harmful effects of oxidation in the respiratory tract, triggering asthmatic symptoms.
The finding could lead to the development of a drug that would target the CaMKII enzyme, the researchers said.
Asthma affects billions of people worldwide, and current treatments don`t work well, Mark Anderson, professor and chair in internal medicine at the UI and a co-corresponding author on the paper, said.
"It`s a kind of an epidemic without a clear, therapeutic option," Anderson said.
"The take-home message is that inhibiting CaMKII appears to be an effective anti-oxidant strategy for treating allergic asthma," he said.
The study is published in the journal Science Translational Medicine.
More from India
More from World
More from Sports
More from Entertaiment
- Coimbatore: PM Narendra Modi unveils 112-foot tall bust of Lord Shiva
- Watch: PM Narendra Modi addressing rally in Imphal
- Will Shiv Sena join hands with Congress to stop BJP from entering BMC?
- Panel discussion on Farooq Abdullah's remark on terrorists
- DNA: Why depression cases are increasing rapidly in India?
- WATCH: Kieron Pollard's epic celebration after destroying Lahore Qalandars in Dubai
- Indian doctor rescued from ISIS recounts horror, says 'they forced me to watch videos, shot me thrice'
- Mitchell Johnson takes a dig at Anil Kumble over calling Steve O'Keefe 'steady'
- India vs Australia, 1st Test, Day 3: As it happened...
- BMC poll results: Shiv Sena approaches Congress for pact, party says 'not interested'